Deva Holding AS
FDA Approved Drugs

Deva Holding AS

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX Discontinued
  • Total Records 32
  • Latest Approval Date Jul 31, 2026
  • Data Source FDA
  • First Approval Date Mar 06, 2017
All
32
View
Discontinued
4
View
RX
28
View
Company Overview

Company

Deva Holding AS

Country

Turkey

Website

Visit Website

Email

MAycicek@deva.com.tr

Social Profiles

LinkedIn
Company Snapshot

Deva Holding AS

Küçükçekmece - İSTANBUL Sicil No: 70061

Turkey

www.deva.com.tr/en/ MAycicek@deva.com.tr View on Map
FDA Approved Drug Records ( 32 records )
2023
13 Sep
RX Application: 209351

Drug Name

AMOXICILLIN AND CLAVULANATE POTASSIUM

Product Number

1

Dosage Form

-

Strength

600MG/5ML;EQ 42.9MG BASE/5ML

Approval Date

2023-09-13

209351 / 1

Active Ingredient

AMOXICILLIN; CLAVULANATE POTASSIUM

Application Number

209351

Product Number

1

Dosage Form

-

Strength

600MG/5ML;EQ 42.9MG BASE/5ML

Approval Date

2023-09-13

Regulatory Status

RX

2023
15 Sep
RX Application: 209991

Drug Name

AMOXICILLIN AND CLAVULANATE POTASSIUM

Product Number

1

Dosage Form

-

Strength

875MG;EQ 125MG BASE

Approval Date

2023-09-15

209991 / 1

Active Ingredient

AMOXICILLIN; CLAVULANATE POTASSIUM

Application Number

209991

Product Number

1

Dosage Form

-

Strength

875MG;EQ 125MG BASE

Approval Date

2023-09-15

Regulatory Status

RX

2023
15 Sep
RX Application: 209992

Drug Name

AMOXICILLIN AND CLAVULANATE POTASSIUM

Product Number

1

Dosage Form

-

Strength

500MG;EQ 125MG BASE

Approval Date

2023-09-15

209992 / 1

Active Ingredient

AMOXICILLIN; CLAVULANATE POTASSIUM

Application Number

209992

Product Number

1

Dosage Form

-

Strength

500MG;EQ 125MG BASE

Approval Date

2023-09-15

Regulatory Status

RX

2023
29 Nov
RX Application: 210374

Drug Name

AMOXICILLIN AND CLAVULANATE POTASSIUM

Product Number

1

Dosage Form

-

Strength

250MG/5ML;EQ 62.5MG BASE/5ML

Approval Date

2023-11-29

210374 / 1

Active Ingredient

AMOXICILLIN; CLAVULANATE POTASSIUM

Application Number

210374

Product Number

1

Dosage Form

-

Strength

250MG/5ML;EQ 62.5MG BASE/5ML

Approval Date

2023-11-29

Regulatory Status

RX

2023
11 Dec
RX Application: 210416

Drug Name

AMOXICILLIN AND CLAVULANATE POTASSIUM

Product Number

1

Dosage Form

-

Strength

400MG/5ML;EQ 57MG BASE/5ML

Approval Date

2023-12-11

210416 / 1

Active Ingredient

AMOXICILLIN; CLAVULANATE POTASSIUM

Application Number

210416

Product Number

1

Dosage Form

-

Strength

400MG/5ML;EQ 57MG BASE/5ML

Approval Date

2023-12-11

Regulatory Status

RX

2024
12 Jan
Discontinued Application: 210197

Drug Name

CEFTRIAXONE

Product Number

1

Dosage Form

-

Strength

EQ 250MG BASE/VIAL

Approval Date

2024-01-12

210197 / 1

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

210197

Product Number

1

Dosage Form

-

Strength

EQ 250MG BASE/VIAL

Approval Date

2024-01-12

Regulatory Status

Discontinued

2024
12 Jan
Discontinued Application: 210197

Drug Name

CEFTRIAXONE

Product Number

2

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2024-01-12

210197 / 2

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

210197

Product Number

2

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2024-01-12

Regulatory Status

Discontinued

2024
12 Jan
Discontinued Application: 210197

Drug Name

CEFTRIAXONE

Product Number

3

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2024-01-12

210197 / 3

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

210197

Product Number

3

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2024-01-12

Regulatory Status

Discontinued

2024
12 Jan
Discontinued Application: 210197

Drug Name

CEFTRIAXONE

Product Number

4

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2024-01-12

210197 / 4

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

210197

Product Number

4

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2024-01-12

Regulatory Status

Discontinued

2024
24 Sep
RX Application: 218229

Drug Name

CHLORPROMAZINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

25MG/ML

Approval Date

2024-09-24

218229 / 1

Active Ingredient

CHLORPROMAZINE HYDROCHLORIDE

Application Number

218229

Product Number

1

Dosage Form

-

Strength

25MG/ML

Approval Date

2024-09-24

Regulatory Status

RX

2024
21 May
RX Application: 209811

Drug Name

CYCLOSPORINE

Product Number

1

Dosage Form

-

Strength

0.05%

Approval Date

2024-05-21

209811 / 1

Active Ingredient

CYCLOSPORINE

Application Number

209811

Product Number

1

Dosage Form

-

Strength

0.05%

Approval Date

2024-05-21

Regulatory Status

RX

2026
31 Jul
RX Application: 217426

Drug Name

EPINEPHRINE

Product Number

1

Dosage Form

-

Strength

1MG/ML (1MG/ML)

Approval Date

2026-07-31

217426 / 1

Active Ingredient

EPINEPHRINE

Application Number

217426

Product Number

1

Dosage Form

-

Strength

1MG/ML (1MG/ML)

Approval Date

2026-07-31

Regulatory Status

RX

2017
06 Mar
RX Application: 207181

Drug Name

ESOMEPRAZOLE SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 40MG BASE/VIAL

Approval Date

2017-03-06

207181 / 1

Active Ingredient

ESOMEPRAZOLE SODIUM

Application Number

207181

Product Number

1

Dosage Form

-

Strength

EQ 40MG BASE/VIAL

Approval Date

2017-03-06

Regulatory Status

RX

2025
11 Feb
RX Application: 218308

Drug Name

FORMOTEROL FUMARATE

Product Number

1

Dosage Form

-

Strength

0.02MG/2ML

Approval Date

2025-02-11

218308 / 1

Active Ingredient

FORMOTEROL FUMARATE

Application Number

218308

Product Number

1

Dosage Form

-

Strength

0.02MG/2ML

Approval Date

2025-02-11

Regulatory Status

RX

2025
10 Dec
RX Application: 213305

Drug Name

ISOPROTERENOL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

0.2MG/ML

Approval Date

2025-12-10

213305 / 1

Active Ingredient

ISOPROTERENOL HYDROCHLORIDE

Application Number

213305

Product Number

1

Dosage Form

-

Strength

0.2MG/ML

Approval Date

2025-12-10

Regulatory Status

RX

2025
22 May
RX Application: 217554

Drug Name

LENALIDOMIDE

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2025-05-22

217554 / 1

Active Ingredient

LENALIDOMIDE

Application Number

217554

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2025-05-22

Regulatory Status

RX

2025
22 May
RX Application: 217554

Drug Name

LENALIDOMIDE

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2025-05-22

217554 / 2

Active Ingredient

LENALIDOMIDE

Application Number

217554

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2025-05-22

Regulatory Status

RX

2025
22 May
RX Application: 217554

Drug Name

LENALIDOMIDE

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2025-05-22

217554 / 3

Active Ingredient

LENALIDOMIDE

Application Number

217554

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2025-05-22

Regulatory Status

RX

2025
22 May
RX Application: 217554

Drug Name

LENALIDOMIDE

Product Number

4

Dosage Form

-

Strength

15MG

Approval Date

2025-05-22

217554 / 4

Active Ingredient

LENALIDOMIDE

Application Number

217554

Product Number

4

Dosage Form

-

Strength

15MG

Approval Date

2025-05-22

Regulatory Status

RX

2025
22 May
RX Application: 217554

Drug Name

LENALIDOMIDE

Product Number

5

Dosage Form

-

Strength

20MG

Approval Date

2025-05-22

217554 / 5

Active Ingredient

LENALIDOMIDE

Application Number

217554

Product Number

5

Dosage Form

-

Strength

20MG

Approval Date

2025-05-22

Regulatory Status

RX

2025
22 May
RX Application: 217554

Drug Name

LENALIDOMIDE

Product Number

6

Dosage Form

-

Strength

25MG

Approval Date

2025-05-22

217554 / 6

Active Ingredient

LENALIDOMIDE

Application Number

217554

Product Number

6

Dosage Form

-

Strength

25MG

Approval Date

2025-05-22

Regulatory Status

RX

2025
30 Jun
RX Application: 217430

Drug Name

LEVOCARNITINE

Product Number

1

Dosage Form

-

Strength

200MG/ML

Approval Date

2025-06-30

217430 / 1

Active Ingredient

LEVOCARNITINE

Application Number

217430

Product Number

1

Dosage Form

-

Strength

200MG/ML

Approval Date

2025-06-30

Regulatory Status

RX

2026
01 May
RX Application: 219941

Drug Name

MIRABEGRON

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2026-05-01

219941 / 1

Active Ingredient

MIRABEGRON

Application Number

219941

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2026-05-01

Regulatory Status

RX

2026
01 May
RX Application: 219941

Drug Name

MIRABEGRON

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2026-05-01

219941 / 2

Active Ingredient

MIRABEGRON

Application Number

219941

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2026-05-01

Regulatory Status

RX

2025
16 May
RX Application: 215074

Drug Name

PANTOPRAZOLE SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 40MG BASE/VIAL

Approval Date

2025-05-16

215074 / 1

Active Ingredient

PANTOPRAZOLE SODIUM

Application Number

215074

Product Number

1

Dosage Form

-

Strength

EQ 40MG BASE/VIAL

Approval Date

2025-05-16

Regulatory Status

RX

2020
21 Dec
RX Application: 214491

Drug Name

SUCCINYLCHOLINE CHLORIDE

Product Number

1

Dosage Form

-

Strength

20MG/ML

Approval Date

2020-12-21

214491 / 1

Active Ingredient

SUCCINYLCHOLINE CHLORIDE

Application Number

214491

Product Number

1

Dosage Form

-

Strength

20MG/ML

Approval Date

2020-12-21

Regulatory Status

RX

2017
26 Apr
RX Application: 207658

Drug Name

TEMOZOLOMIDE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2017-04-26

207658 / 1

Active Ingredient

TEMOZOLOMIDE

Application Number

207658

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2017-04-26

Regulatory Status

RX

2017
26 Apr
RX Application: 207658

Drug Name

TEMOZOLOMIDE

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2017-04-26

207658 / 2

Active Ingredient

TEMOZOLOMIDE

Application Number

207658

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2017-04-26

Regulatory Status

RX

2017
26 Apr
RX Application: 207658

Drug Name

TEMOZOLOMIDE

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2017-04-26

207658 / 3

Active Ingredient

TEMOZOLOMIDE

Application Number

207658

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2017-04-26

Regulatory Status

RX

2017
26 Apr
RX Application: 207658

Drug Name

TEMOZOLOMIDE

Product Number

4

Dosage Form

-

Strength

140MG

Approval Date

2017-04-26

207658 / 4

Active Ingredient

TEMOZOLOMIDE

Application Number

207658

Product Number

4

Dosage Form

-

Strength

140MG

Approval Date

2017-04-26

Regulatory Status

RX

2017
26 Apr
RX Application: 207658

Drug Name

TEMOZOLOMIDE

Product Number

5

Dosage Form

-

Strength

180MG

Approval Date

2017-04-26

207658 / 5

Active Ingredient

TEMOZOLOMIDE

Application Number

207658

Product Number

5

Dosage Form

-

Strength

180MG

Approval Date

2017-04-26

Regulatory Status

RX

2017
26 Apr
RX Application: 207658

Drug Name

TEMOZOLOMIDE

Product Number

6

Dosage Form

-

Strength

250MG

Approval Date

2017-04-26

207658 / 6

Active Ingredient

TEMOZOLOMIDE

Application Number

207658

Product Number

6

Dosage Form

-

Strength

250MG

Approval Date

2017-04-26

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    8 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    32 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
32 total
  • RX
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

AMOXICILLIN AND CLAVULANATE POTASSIUM

Application Number

209351

Product Number

1

Active Ingredient

AMOXICILLIN; CLAVULANATE POTASSIUM

Dosage Form

-

Strength

600MG/5ML;EQ 42.9MG BASE/5ML

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit